Home LiteratureArticle Details
PMID: 12050354 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Highly pathogenic simian immunodeficiency virus mne variants that emerge during the course of infection evolve enhanced infectivity and the ability to downregulate CD4 but not class I major histocompatibility complex antigens.

Journal of virology ·Vol. 76 ·No. 13 ·2002-07-00 ·Pages 6425-34

Patel PG, Yu Kimata MT, Biggins JE, Wilson JM, Kimata JT

Abstract

The replicative, cytopathic, and antigenic properties of simian immunodeficiency virus (SIV) variants influence its replication efficiency in vivo. To further define the viral properties and determinants that may be important for high-level replication in vivo and progression to AIDS, we compared a minimally pathogenic SIVmne molecular clone with two highly pathogenic variants cloned from late stages of infection. Both variants had evolved greater infectivity than the parental clone due to mutations in nef. Interestingly, a pol determinant in one of the highly pathogenic variants also contributed to its increased infectivity. Furthermore, because replication in vivo may also be influenced by the ability of a virus to evade the cellular immune response of the host, we examined whether the variants were more capable of downregulating surface expression of class I major histocompatibility complex (MHC). Decreased MHC class I expression was not observed in cells infected with any of the viruses. Furthermore, the Nef proteins of the highly pathogenic variants only slightly reduced surface MHC class I expression in transfected cells, although they efficiently downregulated CD4. Together, these data demonstrate that mutations which can enhance viral infectivity, as well as CD4 downregulation, may be important for efficient replication of SIV in the host. However, Nef-mediated reduction of MHC class I expression does not appear to be critical for the increased in vivo replicative ability of highly pathogenic late variants.

MeSH Terms
Amino Acid Sequence Animals CD4 Antigens/metabolism Cell Line Down-Regulation Gene Products, nef/chemistry,physiology Genetic Variation Histocompatibility Antigens Class I/metabolism Humans Leukocytes, Mononuclear/virology Macaca nemestrina Molecular Sequence Data Simian Acquired Immunodeficiency Syndrome/virology Simian Immunodeficiency Virus/genetics,pathogenicity,physiology Virus Replication
Chemicals
CD4 Antigens Gene Products, nef Histocompatibility Antigens Class I
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Patel Parul G
Department of Virology and Immunology, Southwest Foundation for Biomedical Research, 7620 NW Loop 410 @ Military Drive, San Antonio, TX 78227, USA.
Yu Kimata Monica T
Biggins Julia E
Wilson Joelle M
Kimata Jason T
References (74)
74 references, click to expand
  1. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes.
    J Exp Med. 1994 Jan 1;179(1):115-23 PMID: 7903679
  2. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene.
    J Virol. 1994 May;68(5):2906-14 PMID: 8151761
  3. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression.
    J Virol. 1994 Jul;68(7):4400-8 PMID: 7515972
  4. The biological phenotype of HIV-1 is usually retained during and after sexual transmission.
    Virology. 1994 Oct;204(1):297-303 PMID: 8091660
  5. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.
    N Engl J Med. 1995 Jan 26;332(4):228-32 PMID: 7808489
  6. Viral dynamics in human immunodeficiency virus type 1 infection.
    Nature. 1995 Jan 12;373(6510):117-22 PMID: 7529365
  7. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.
    Nature. 1995 Jan 12;373(6510):123-6 PMID: 7816094
  8. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages.
    Nat Med. 1999 Sep;5(9):997-103 PMID: 10470075
  9. Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation.
    J Virol. 2000 Mar;74(6):2907-12 PMID: 10684310
  10. Interactions of HIV-1 NEF with cellular signal transducing proteins.
    Front Biosci. 2000 Feb 1;5:D268-83 PMID: 10704155
  11. Macaques infected with cloned simian immunodeficiency virus show recurring nef gene alterations.
    Virology. 1998 Sep 30;249(2):260-74 PMID: 9791018
  12. Association of simian immunodeficiency virus Nef with the T-cell receptor (TCR) zeta chain leads to TCR down-modulation.
    J Gen Virol. 1998 Nov;79 ( Pt 11):2717-27 PMID: 9820147
  13. Coreceptor specificity of temporal variants of simian immunodeficiency virus Mne.
    J Virol. 1999 Feb;73(2):1655-60 PMID: 9882375
  14. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques.
    Nat Med. 1999 Feb;5(2):194-203 PMID: 9930868
  15. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain.
    J Exp Med. 1999 May 3;189(9):1489-96 PMID: 10224289
  16. Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression.
    Nat Med. 1999 May;5(5):535-41 PMID: 10229230
  17. Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease.
    J Virol. 1999 Jul;73(7):5497-508 PMID: 10364298
  18. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein.
    Curr Biol. 1999 Jun 17;9(12):613-21 PMID: 10375525
  19. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner.
    Curr Biol. 1999 Jun 17;9(12):622-31 PMID: 10375528
  20. HIV-1 Nef increases T cell activation in a stimulus-dependent manner.
    Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8167-72 PMID: 10393966
  21. Pathogenesis of simian immunodeficiency virus infection.
    J Gen Virol. 1999 Jul;80 ( Pt 7):1557-68 PMID: 10423122
  22. CD4 down-modulation by human immunodeficiency virus type 1 Nef correlates with the efficiency of viral replication and with CD4(+) T-cell depletion in human lymphoid tissue ex vivo.
    J Virol. 2001 Nov;75(21):10113-7 PMID: 11581379
  23. Efficient class I major histocompatibility complex down-regulation by simian immunodeficiency virus Nef is associated with a strong selective advantage in infected rhesus macaques.
    J Virol. 2001 Nov;75(21):10532-6 PMID: 11581427
  24. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection.
    Lancet. 1986 Sep 20;2(8508):660-2 PMID: 2429124
  25. Biologic features of HIV-1 that correlate with virulence in the host.
    Science. 1988 Apr 1;240(4848):80-2 PMID: 2832945
  26. Inoculation of baboons and macaques with simian immunodeficiency virus/Mne, a primate lentivirus closely related to human immunodeficiency virus type 2.
    J Virol. 1988 Jun;62(6):2091-101 PMID: 3285032
  27. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates.
    J Virol. 1988 Nov;62(11):4414-9 PMID: 2459416
  28. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.
    J Virol. 1989 May;63(5):2118-25 PMID: 2564898
  29. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality.
    Lancet. 1989 May 6;1(8645):983-5 PMID: 2565516
  30. SIV adaptation to human cells.
    Nature. 1989 Oct 19;341(6243):573-4 PMID: 2677749
  31. Replicative capacity, cytopathic effect and cell tropism of HIV.
    AIDS. 1989;3 Suppl 1:S5-12 PMID: 2514754
  32. CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor.
    J Virol. 1990 Nov;64(11):5585-93 PMID: 2214026
  33. Simian and human immunodeficiency virus Nef proteins use different surfaces to downregulate class I major histocompatibility complex antigen expression.
    J Virol. 2000 Jun;74(12):5691-701 PMID: 10823877
  34. Disrupting surfaces of nef required for downregulation of CD4 and for enhancement of virion infectivity attenuates simian immunodeficiency virus replication in vivo.
    J Virol. 2000 Nov;74(21):9836-44 PMID: 11024110
  35. Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS.
    J Virol. 2001 Apr;75(8):3657-65 PMID: 11264355
  36. HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell.
    Nature. 2001 Apr 12;410(6830):834-8 PMID: 11298454
  37. Selection forces and constraints on retroviral sequence variation.
    Science. 2001 May 11;292(5519):1106-9 PMID: 11352065
  38. Identification of a simian immunodeficiency virus reverse transcriptase variant with enhanced replicational fidelity in the late stage of viral infection.
    J Biol Chem. 2001 Jun 29;276(26):23624-31 PMID: 11325971
  39. Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA.
    Science. 2001 Aug 24;293(5534):1503-6 PMID: 11520990
  40. Changing virus-host interactions in the course of HIV-1 infection.
    Immunol Rev. 1994 Aug;140:35-72 PMID: 7821927
  41. Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population.
    Virology. 1995 Mar 10;207(2):528-42 PMID: 7886956
  42. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion.
    Ann Intern Med. 1995 Apr 15;122(8):573-9 PMID: 7887550
  43. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques.
    Science. 1995 Mar 24;267(5205):1820-5 PMID: 7892606
  44. Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef.
    J Virol. 1995 Jul;69(7):4112-21 PMID: 7769669
  45. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis.
    J Virol. 1995 Aug;69(8):5048-56 PMID: 7541845
  46. The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation.
    Virology. 1995 Oct 1;212(2):451-7 PMID: 7571414
  47. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.
    Science. 1995 Nov 10;270(5238):988-91 PMID: 7481804
  48. Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates.
    Virology. 1995 Nov 10;213(2):386-94 PMID: 7491763
  49. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.
    N Engl J Med. 1996 Feb 15;334(7):426-31 PMID: 8552144
  50. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein.
    Nat Med. 1996 Mar;2(3):338-42 PMID: 8612235
  51. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.
    Science. 1996 May 24;272(5265):1167-70 PMID: 8638160
  52. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study.
    JAMA. 1996 Jul 10;276(2):105-10 PMID: 8656501
  53. High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection.
    J Virol. 1996 Nov;70(11):7752-64 PMID: 8892896
  54. Change in coreceptor use correlates with disease progression in HIV-1--infected individuals.
    J Exp Med. 1997 Feb 17;185(4):621-8 PMID: 9034141
  55. Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling.
    EMBO J. 1997 Feb 17;16(4):673-84 PMID: 9049297
  56. A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation.
    J Virol. 1997 Aug;71(8):6094-9 PMID: 9223503
  57. Association of simian immunodeficiency virus Nef with cellular serine/threonine kinases is dispensable for the development of AIDS in rhesus macaques.
    Nat Med. 1997 Aug;3(8):860-5 PMID: 9256276
  58. The cytopathicity of a simian immunodeficiency virus Mne variant is determined by mutations in Gag and Env.
    J Virol. 1997 Oct;71(10):7629-39 PMID: 9311845
  59. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies.
    J Virol. 1997 Oct;71(10):7719-27 PMID: 9311856
  60. Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition.
    J Virol. 1998 Jan;72(1):209-17 PMID: 9420217
  61. A lymph node-derived cytopathic simian immunodeficiency virus Mne variant replicates in nonstimulated peripheral blood mononuclear cells.
    J Virol. 1998 Jan;72(1):245-56 PMID: 9420221
  62. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.
    Nature. 1998 Jan 22;391(6665):397-401 PMID: 9450757
  63. Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency.
    Nat Med. 1998 Mar;4(3):346-9 PMID: 9500611
  64. T cell responses and viral escape.
    Cell. 1998 May 29;93(5):673-6 PMID: 9630211
  65. Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.
    J Virol. 1998 Sep;72(9):7501-9 PMID: 9696847
  66. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef.
    Nature. 1991 Apr 11;350(6318):508-11 PMID: 2014052
  67. Importance of the nef gene for maintenance of high virus loads and for development of AIDS.
    Cell. 1991 May 17;65(4):651-62 PMID: 2032289
  68. Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS.
    J Virol. 1991 Dec;65(12):7025-31 PMID: 1942255
  69. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population.
    J Virol. 1992 Mar;66(3):1354-60 PMID: 1738194
  70. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene.
    EMBO J. 1993 Feb;12(2):703-13 PMID: 8095017
  71. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals.
    J Virol. 1993 Apr;67(4):1772-7 PMID: 8095306
  72. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.
    Science. 1993 Mar 19;259(5102):1749-54 PMID: 8096089
  73. Pathogenesis of human immunodeficiency virus infection.
    Microbiol Rev. 1993 Mar;57(1):183-289 PMID: 8464405
  74. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.
    J Exp Med. 1994 Jan 1;179(1):101-13 PMID: 8270859
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2002-07-00
Pages
6425-34
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC136284
Subset
IM
Grants
NIAID NIH HHS · R56 AI047725 · United States
NIAID NIH HHS · AI 47725 · United States
NIAID NIH HHS · T32 AI007522 · United States
NIAID NIH HHS · R01 AI047725 · United States
NIAID NIH HHS · AI 07522 · United States
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com